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Reply to Salviati et al.
To the Editor: In this issue, Salviati and colleagues report
the case of an 8-year-old girl whose mild developmental
delay and dysmorphic features led them to perform a
high-resolution karyotype.1 A 12-Mb deletion located in
10q23 and encompassing the PTEN and BMPR1A loci was
detected. The child presented with rectal bleeding at age
5 years. Colonoscopy at age 6 years uncovered 115 ha-
martomatous polyps throughout the entire colon, allow-
ing the diagnosis of juvenile polyposis (JP). By operational
definition, JP in patients younger than 6 years may be
classified as “JP of infancy.” Thus, the rectal bleeding in
this child at age 5 years was almost certainly due to the
juvenile polyps uncovered only the following year; there-
fore, this case corroborates our report.2 However, the pre-
sentation and the disease course of the patient reported
by Salviati et al.1 were not as severe as those of the four
patients reported in our recent study2 and about which
we hypothesize that the cooperation of the deletions of
both tumor-suppressor genes PTEN and BMPR1A leads to
severe JP and, hence, to cases of JP of infancy. The report
by Salviati and colleagues1 is very interesting, illustrating
that a very large deletion (12 Mb, compared with 2 Mb
in patients 1 and 2 in our report2 and ∼4.8 Mb in the
patient reported by Tsuchiya et al.3) may be, paradoxically,
associated with a less severe disease course than a small
deletion or a point mutation. As proposed by Salviati and
colleagues,1 the protective effect of a modifier allele of a
gene unlinked to the PTEN and BMPR1A genes may ex-
plain this phenomenon even if, at the present time, no
candidate gene is suggested. Another explanation for this
milder phenotype may be the increased expression level
of the PTEN and BMPR1A genes by the remaining allele,
which thus allows correction of the haploinsufficiency.
Indeed, evidence is accumulating that allelic-specific ex-
pression is relatively common among nonimprinted au-
tosomal genes and may be due to cis-acting, genetically
inherited variations.4 Because of the very large size of the
10q22.3-q23 deletion in the patient reported by Salviati
and colleagues,1 we speculate that, without the increased
expression level by the remaining chromosome of some
critical genes other than PTEN and BMPR1A located in the
deleted region, this condition would have been lethal.
Thus, we suggest that the affected child may have some
cis-acting–specific sequences in the remaining allele that
correct the haploinsufficiency in the 10q22.3-q23 region
and lead, paradoxically, to an attenuated phenotype. The
study by Salviati et al.1 illustrates how meticulous analyses
of cases presenting with a similar disease are useful. To-
gether with our original publication, this study should
spur the international community to cooperatively and
systematically study all JP syndrome diagnoses, the fre-
quency of deletion of either or both genes, and their pre-
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cise phenotypic manifestations, including age at onset and
severity.
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